BIOMAT Database Logo BIOMAT Database Logo

1,4-diarylpiperazines and analogs as anti-tubercular agents: synthesis and biological evaluation. 2012

D Forge, and D Cappoen, and J Laurent, and D Stanicki, and A Mayence, and T L Huang, and L Verschaeve, and K Huygen, and J J Vanden Eynde
University of Mons-UMONS, Laboratory of Organic Chemistry, Mons, Belgium.

Despite progress in modern chemotherapy to combat tuberculosis, the causative pathogen Mycobacterium tuberculosis (M.tb.) is far from eradicated. Bacillary resistance to anti-mycobacterial agents, bacillary persistence and human immunodeficiency virus (HIV) co-infection hamper current drug treatment to completely cure the infection, generating a constant demand for novel drug candidates to tackle these problems. A small library of novel heterocyclic compounds was screened in a rapid luminometric in vitro assay against the laboratory M.tb. strain H37Rv. A group of amidines was found to have the highest potency and was further evaluated for acute toxicity against C3A hepatocytes. Next, the most promising compounds were evaluated for activity against a multi-drug resistant clinical isolate. The group of amidines was also tested for their ability to kill intracellular M.tb. residing in mouse J774A.1 macrophages. Finally, we report on a correlation between the structural differences of the compounds and their anti-mycobacterial activity.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

D Forge, and D Cappoen, and J Laurent, and D Stanicki, and A Mayence, and T L Huang, and L Verschaeve, and K Huygen, and J J Vanden Eynde
Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents.
September 2018, European journal of medicinal chemistry,
D Forge, and D Cappoen, and J Laurent, and D Stanicki, and A Mayence, and T L Huang, and L Verschaeve, and K Huygen, and J J Vanden Eynde
Design, Synthesis and Biological Evaluation of Novel Spiro-[Chroman-2,4'-Piperidin]-4-One Analogs as Anti-Tubercular Agents.
August 2022, Chemistry & biodiversity,
D Forge, and D Cappoen, and J Laurent, and D Stanicki, and A Mayence, and T L Huang, and L Verschaeve, and K Huygen, and J J Vanden Eynde
Design, synthesis, and biological evaluation of novel arylcarboxamide derivatives as anti-tubercular agents.
February 2020, RSC advances,
D Forge, and D Cappoen, and J Laurent, and D Stanicki, and A Mayence, and T L Huang, and L Verschaeve, and K Huygen, and J J Vanden Eynde
1,2,3-Triazole-fused spirochromenes as potential anti-tubercular agents: synthesis and biological evaluation.
May 2018, RSC advances,
D Forge, and D Cappoen, and J Laurent, and D Stanicki, and A Mayence, and T L Huang, and L Verschaeve, and K Huygen, and J J Vanden Eynde
Synthesis and biological evaluation of novel 1,2,3-triazole derivatives as anti-tubercular agents.
August 2017, Bioorganic & medicinal chemistry letters,
D Forge, and D Cappoen, and J Laurent, and D Stanicki, and A Mayence, and T L Huang, and L Verschaeve, and K Huygen, and J J Vanden Eynde
Synthesis and biological evaluation of imidamide analogs as selective anti-trypanosomal agents.
May 2022, Bioorganic & medicinal chemistry,
D Forge, and D Cappoen, and J Laurent, and D Stanicki, and A Mayence, and T L Huang, and L Verschaeve, and K Huygen, and J J Vanden Eynde
Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents.
June 2016, Bioorganic & medicinal chemistry letters,
D Forge, and D Cappoen, and J Laurent, and D Stanicki, and A Mayence, and T L Huang, and L Verschaeve, and K Huygen, and J J Vanden Eynde
Synthesis and biological evaluation of some new 1,4-dihydropyridines containing different ester substitute and diethyl carbamoyl group as anti-tubercular agents.
February 2009, Bioorganic & medicinal chemistry,
D Forge, and D Cappoen, and J Laurent, and D Stanicki, and A Mayence, and T L Huang, and L Verschaeve, and K Huygen, and J J Vanden Eynde
Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents.
July 2004, Bioorganic & medicinal chemistry,
D Forge, and D Cappoen, and J Laurent, and D Stanicki, and A Mayence, and T L Huang, and L Verschaeve, and K Huygen, and J J Vanden Eynde
Design, synthesis, and biological evaluation of steroidal analogs as estrogenic/anti-estrogenic agents.
February 2017, Steroids,
Copied contents to your clipboard!